Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H16N4O2S |
InChIKeyNHJCZZWENDYDEP-UHFFFAOYSA-N |
CAS Registry708991-09-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 21 May 2016 |